HomeCompareEXPGY vs MRK

EXPGY vs MRK: Dividend Comparison 2026

EXPGY yields 1.81% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $24.2K in total portfolio value
10 years
EXPGY
EXPGY
● Live price
1.81%
Share price
$34.94
Annual div
$0.63
5Y div CAGR
26.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.6K
Annual income
$2,951.77
Full EXPGY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — EXPGY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEXPGYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EXPGY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EXPGY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXPGY
Annual income on $10K today (after 15% tax)
$153.87/yr
After 10yr DRIP, annual income (after tax)
$2,509.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $5,819.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXPGY + MRK for your $10,000?

EXPGY: 50%MRK: 50%
100% MRK50/50100% EXPGY
Portfolio after 10yr
$44.7K
Annual income
$6,374.95/yr
Blended yield
14.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EXPGY
Analyst Ratings
4
Buy
2
Hold
Consensus: Buy
Altman Z
6.4
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXPGY buys
0
MRK buys
0
No recent congressional trades found for EXPGY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEXPGYMRK
Forward yield1.81%2.76%
Annual dividend / share$0.63$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR26.9%32.7%
Portfolio after 10y$32.6K$56.8K
Annual income after 10y$2,951.77$9,798.13
Total dividends collected$10.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: EXPGY vs MRK ($10,000, DRIP)

YearEXPGY PortfolioEXPGY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,930$229.72$11,206$366.19$276.00MRK
2$11,993$297.77$12,650$502.35$657.00MRK
3$13,220$387.50$14,407$694.19$1.2KMRK
4$14,652$506.58$16,585$967.82$1.9KMRK
5$16,343$665.88$19,342$1,363.89$3.0KMRK
6$18,368$880.89$22,913$1,947.19$4.5KMRK
7$20,828$1,174.15$27,662$2,823.89$6.8KMRK
8$23,865$1,579.02$34,159$4,173.35$10.3KMRK
9$27,681$2,145.75$43,337$6,308.80$15.7KMRK
10$32,570$2,951.77$56,776$9,798.13$24.2KMRK

EXPGY vs MRK: Complete Analysis 2026

EXPGYStock

Experian plc, together with its subsidiaries, operates as a technology company. The company operates through two segments, Business-to-Business and Consumer Services. It provides data services to identify and understand the customers, as well as to manage the risks related with lending. The company also offers analytical and decision tools that enhance businesses to manage their customers, minimize the risk of fraud, comply with legal requirements, and automate decisions and processes. In addition, it provides financial education, free access to Experian credit reports and scores, online educational tools, and applications to manage their financial position, access credit offers, and protect themselves from identity fraud. The company serves customers in financial service, direct-to-consumer, health, retail, automotive, software and professional services, telecommunications and utility, insurance, media and technology, government and public, and other sectors. It operates in North America, Latin America, the United Kingdom, Ireland, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Experian Group Limited and changed its name to Experian plc in July 2008. Experian plc was founded in 1826 and is headquartered in Dublin, Ireland.

Full EXPGY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EXPGY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXPGY vs SCHDEXPGY vs JEPIEXPGY vs OEXPGY vs KOEXPGY vs MAINEXPGY vs JNJEXPGY vs ABBVEXPGY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.